Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) treated with 2-chlorodeoxyadenosine |
| |
Authors: | Tasso M Esquembre C Blanco E Moscardó C Niveiro M Payá A |
| |
Affiliation: | Division of Pediatric Oncology, Hospital General Universitario de Alicante, Alicante, Spain. tasso_mar@gva.es |
| |
Abstract: | ![]() Sinus histiocytosis with massive lymphadenopathy (SHML) or Rosai-Dorfman disease (RDD) is a rare but well-defined histiocytic proliferative disorder of unknown etiology that usually presents with cervical lymphadenopathy, fever, leukocytosis, and hypergammaglobulinemia in an otherwise healthy child. Although many patients undergo spontaneous remission, a subset of patients with systemic disease has a more serious course. For those patients with a poor outcome, steroids and chemotherapeutic agents such as etoposide or 6-mercaptopurine plus low dose methotrexate have been used. We present a child with a massive cervical lymphadenopathy treated with 2-chlorodeoxyadenosine (2-CdA, cladribine) after other approaches failed. |
| |
Keywords: | cladribine Rosai–Dorfman disease sinus histiocytosis 2‐CdA 2‐chlorodeoxyadenosine |
本文献已被 PubMed 等数据库收录! |
|